MyndTec Announces Results of Annual General and Special Meeting of Shareholders
Mississauga, Ontario--(Newsfile Corp. - June 26, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, announces the voting results from its annual general and special meeting of shareholders (the "Meeting") held on June 18, 2025.The five (5) candidates nominated for election...
Technology, Healthcare and Hospitals, Health
2025-06-26 4:30 PM EDT | MyndTec Inc.
Canadian Institute of Actuaries Announces Alicia Rollo as New Executive Director
Ottawa, Ontario--(Newsfile Corp. - June 26, 2025) - As the Canadian Institute of Actuaries (CIA) looks to the future, it welcomes new leadership, celebrates a legacy of service and shares key milestones in its continued advancement of the actuarial profession in Canada.Alicia Rollo appointed Executive Director, effective July 1, 2025The...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-26 12:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
L'Institut canadien des actuaires annonce la nomination d'Alicia Rollo au poste de directrice générale
Ottawa, Ontario--(Newsfile Corp. - 26 juin 2025) - Se tournant vers l'avenir, l'Institut canadien des actuaires accueille une nouvelle dirigeante, célèbre un héritage de service et partage des jalons importants de la progression soutenue de la profession actuarielle au Canada.Nomination d'Alicia Rollo au poste de directrice générale à compter du...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-26 12:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
Apollo Biowellness, Inc., f/k/a Resonate Blends, Inc., Corporate Update
North Bergen, New Jersey--(Newsfile Corp. - June 26, 2025) - Apollo Biowellness, Inc. formerly known as Resonate Blends, Inc. (OTC Pink: KOAN) (the "Company"), announces that it is fully compliant and is current in its filing. The Company is preparing to be listed on OTCIQ and is pleased to...
Household/Consumer/Cosmetics, Health
2025-06-26 10:00 AM EDT | Apollo Biowellness, Inc.
Liviniti Achieves HITRUST i1 Certification for Industry-Leading Security Practices
Certification demonstrates Liviniti's strong commitment to data security and risk managementNatchitoches, Louisiana--(Newsfile Corp. - June 26, 2025) - Liviniti, a national leader in PBM transparency and prescription drug savings, today announced it has achieved 2025 certified HITRUST status for information security. Platforms with HITRUST certification include the Liviniti client portal,...
2025-06-26 9:08 AM EDT | Liviniti
Hemostemix Announces Lead Order of $1,500,000 and the Full Repayment of $2,500,000 Convertible Debenture
Calgary, Alberta--(Newsfile Corp. - June 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces its Chairman, Peter Lacey, has provided the Company with a lead order for a non brokered private placement in the amount of $1,500,000 for Units at $0.10. Each Unit...
Biotechnology, Pharmaceuticals, Health
2025-06-26 9:00 AM EDT | Hemostemix Inc.
Edison Issues Report on Lamda Development (LAMDA)
London, United Kingdom--(Newsfile Corp. - June 26, 2025) - Edison issues report on Lamda Development (ASE: LAMDA).LAMDA Development is the largest mall owner and operator in Greece and is currently developing The Ellinikon, Europe's biggest urban regeneration project. LAMDA's core mall portfolio will expand to six developments, plus two existing...
Banking/Financial Services, Computer Hardware, Computer Software, Health
2025-06-26 8:37 AM EDT | Edison Group
Medexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States
Fiscal year 2025 revenue of $108.3 million, record net income of $2.2 million, operating income of $8.2 million, and record Adjusted EBITDA* of $20.2 millionUS commercial launch of GRAFAPEX™ executed in February 2025, following swiftly on the FDA's approval in January 2025, with initial indicators supporting Medexus's confidence in the...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-25 6:15 PM EDT | Medexus Pharmaceuticals Inc.
Unbuzzd Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM – the scientifically-proven and game-changing beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms - is pleased to announce that it has engaged MZ Digital, a global...
2025-06-25 8:30 AM EDT | Unbuzzd Wellness Inc.
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort
-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in fourth cohort, permitting dose escalation in expected final cohortMarlborough, Massachusetts--(Newsfile Corp. - June 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer....
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-25 7:45 AM EDT | Phio Pharmaceuticals Corp.
Edison Issues Report on Verve Group (VRV)
London, United Kingdom--(Newsfile Corp. - June 25, 2025) - Edison issues report on Verve Group (FRA: VRV).The Verve Group has successfully completed a directed share issue of 12.9m new shares, raising SEK360m (€32.5m), with which it intends to scale its sales capacity, develop new product solutions, invest further in AI...
Banking/Financial Services, Computer Hardware, Computer Software, Health
2025-06-25 7:40 AM EDT | Edison Group
PreveCeutical Announces Date for Annual General and Special Meeting
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has scheduled its annual general and special meeting for August 15, 2025, at which the shareholders (the "PreveCeutical Shareholders") of the Company will be...
Biotechnology, Pharmaceuticals, Health
2025-06-25 7:00 AM EDT | PreveCeutical Medical Inc.
Cosmo Announces Sale of "Digital Trust" in Strategic Portfolio Streamlining Move
Dublin, Ireland--(Newsfile Corp. - June 25, 2025) - Cosmo today announced the signing of an agreement to sell “Digital Trust” to its existing customer Tinexta InfoCert, Europe’s largest Certification Authority and a subsidiary of Tinexta S.p.A., a publicly listed...
Healthcare and Hospitals, Health
2025-06-25 1:06 AM EDT | Cosmo Pharmaceuticals N.V.
LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading On TSX Venture Exchange
Toronto, Ontario--(Newsfile Corp. - June 24, 2025) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its news release of June 23, 2025, the Ontario Securities Commission (the "OSC") has revoked a Failure-to-File Cease Trade Order (the "FFCTO") that had been originally issued by the...
Healthcare and Hospitals, Health
2025-06-24 1:55 PM EDT | LevelJump Healthcare Corp.
Adia Nutrition Inc. Unveils Game-Changing Nationwide TV Commercial for Adia Vita: A New Era in Regenerative Medicine
Winter Park, Florida--(Newsfile Corp. - June 24, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in the $15.1 billion global stem cell market, today ignited a revolution with the launch of its electrifying nationwide TV commercial for Adia Vita. Utilizing the innovative technology platform MNTN (NYSE: MNTN), which...
Healthcare and Hospitals, Health
2025-06-24 8:44 AM EDT | Adia Nutrition Inc.
Hadley and Notal Vision Partner to Empower Patients with Vision Loss Through Education and Leading Technology
Winnetka, Illinois--(Newsfile Corp. - June 24, 2025) - Hadley, a leading nonprofit empowering people with vision loss to adapt and thrive, and Notal Vision, a pioneer in AI-driven home diagnostic tools and digital healthcare for retinal diseases, today announced a strategic partnership to bridge the gap between early detection, treatment...
Healthcare and Hospitals, Health
2025-06-24 8:00 AM EDT | Notal Vision
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Marlborough, Massachusetts--(Newsfile Corp. - June 24, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-24 7:45 AM EDT | Phio Pharmaceuticals Corp.
cbdMD Expands Oasis Social Tonics to Total Wine
Charlotte, North Carolina--(Newsfile Corp. - June 24, 2025) - cbdMD, Inc. (NYSE American: YCBD), a trusted leader in the wellness and cannabinoid industry, is proud to announce the retail debut of its Herbal Oasis Social Tonics at select Total Wine in Charlotte and surrounding North Carolina areas. The premium line...
Household/Consumer/Cosmetics, Sports, Cannabis, Health
2025-06-24 7:00 AM EDT | cbdMD
Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius(TM) with Apple Vision Pro at Rush University Medical Center
Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that in July 2025, it will initiate their first usability study of a medical device software application connecting the Medtronic GI Genius™ intelligent endoscopy module,...
Healthcare and Hospitals, Health
2025-06-24 1:06 AM EDT | Cosmo Pharmaceuticals N.V.
LevelJump Announces 2025 First Quarter Results; Anticipates Revocation of Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - June 23, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months ended March 31, 2025.Financial and Operational HighlightsRevenues were $4.58 million in the first quarter of 2025 compared to $4.06 million in the same period...
Healthcare and Hospitals, Health
2025-06-23 11:50 AM EDT | LevelJump Healthcare Corp.